Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Eisai
Woman and Man Max 99 years
Eisai Ltd
Update Il y a 4 ans
A double-blind, randomised, placebo-controlled, multi-centre study to assess the efficacy and safety of adjunctive zonisamide in paediatric partial onset seizures
To assess the efficacy of zonisamide in paediatric epilepsy subjects with partial onset seizures treated with one or two other AEDs.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman
Between 18 years
and 99 years
Eisai Medical Research Inc.
Update Il y a 4 ans
Eisai EMBRACE : Essai de phase 3 randomisé comparant l'efficacité d'un traitement par eribulin à un traitement au choix du médecin chez des patientes ayant un cancer du sein. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
L’objectif de l’essai est de comparer l’efficacité d'un traitement par E7389 à un traitement au choix du médecin chez des patientes ayant un cancer du sein. Les patientes seront réparties de façon al...
Country
France
organs
Sein
Specialty
Thérapies Ciblées
,
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man
Between 2 years and 25 years
Eisai Medical Research Inc.
Update Il y a 6 ans
Étude E7080-G000-207 : étude non-randomisée de phase 1 / 2 évaluant la sécurité, la tolérance et l’efficacité du lenvatinib chez des enfants et des adolescents ayant une tumeur solide maligne réfractaire ou récidivante et des jeunes adultes ayant un ostéosarcome.
Le cancer est la première cause de mortalité par maladie chez les enfants et les adolescents. Le cancer de la thyroïde pédiatrique représente 10% des tumeurs malignes et 35% des carcinomes infantiles....
Country
France
organs
Tumeurs solides
,
Os
Specialty
Thérapies Ciblées
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
An open label study of Zonegran (zonisamide) in patients with partial onset seizures
To determine the efficacy and safety of adjunctive open label zonisamide treatment in patients with refractory partial seizures
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients with Severe Sepsis
To demonstrate that eritoran tetrasodium treatment of subjects with severe sepsis results in a reduction in 28-day all-cause mortality.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
A Double-blind, Placebo-controlled, Dose-escalation, Parallel Group Study of E2007 given as Adjunctive Therapy in Patients with Refractory Partial Seizures
- To determine the maximal tolerated dose (MTD) of E2007 when added to concomitant antiepileptic drugs (AEDs), given bid or qd to patients with refractory partial onset seizures (including secondarily...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
A research study to assess whether lorcaserin HCl affects the risk of developing cardiovascular diseases in obese or overweight men and women at higher risk of developing these diseases
-To demonstrate that, in obese and overweight subjects with cardiovascular (CV) disease and/or multiple CV risk factors, lorcaserin HCl 10 mg administered twice daily (BID) does not increase the incid...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
A Multi-Center, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of E2007 (Perampanel) in Patients with Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)
The primary objective is to evaluate long-term (1-year) safety while administering perampanel to patients with PDN or PHN.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children with Attention Impairment Following Cancer Treatment
To evaluate the efficacy of donepezil in children with attention impairment that is present at least 12 months after the completion of cancer treatment
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
A 14-Month Open-Label Extension Phase of the Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 as an Adjunctive Therapy in Patients With Refractory Partial Seizures (revised per Amendments 02 and 03)
The primary objective for this study is to evaluate the safety of E2007 given as adjunctive, long-term treatment in patients with refractory partial onset seizures with or without secondary generaliza...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
5
6
7
8
9
Next